vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and Sally Beauty Holdings, Inc. (SBH). Click either name above to swap in a different company.
Sally Beauty Holdings, Inc. is the larger business by last-quarter revenue ($943.2M vs $493.8M, roughly 1.9× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 4.8%, a 2.0% gap on every dollar of revenue. On growth, Sally Beauty Holdings, Inc. posted the faster year-over-year revenue change (0.6% vs -1.7%). Over the past eight quarters, Sally Beauty Holdings, Inc.'s revenue compounded faster (1.9% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Sally Beauty Holdings, Inc. is an American international specialty retailer and distributor of professional beauty supplies with revenues of more than $3.9 billion annually.
MD vs SBH — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $943.2M |
| Net Profit | $33.7M | $45.6M |
| Gross Margin | — | 51.2% |
| Operating Margin | 9.9% | 8.1% |
| Net Margin | 6.8% | 4.8% |
| Revenue YoY | -1.7% | 0.6% |
| Net Profit YoY | 10.5% | -25.3% |
| EPS (diluted) | $0.40 | $0.45 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $943.2M | ||
| Q3 25 | $492.9M | $947.1M | ||
| Q2 25 | $468.8M | $933.3M | ||
| Q1 25 | $458.4M | $883.1M | ||
| Q4 24 | $502.4M | $937.9M | ||
| Q3 24 | $511.2M | $935.0M | ||
| Q2 24 | $504.3M | $942.3M | ||
| Q1 24 | $495.1M | $908.4M |
| Q4 25 | $33.7M | $45.6M | ||
| Q3 25 | $71.7M | $49.9M | ||
| Q2 25 | $39.3M | $45.7M | ||
| Q1 25 | $20.7M | $39.2M | ||
| Q4 24 | $30.5M | $61.0M | ||
| Q3 24 | $19.4M | $48.1M | ||
| Q2 24 | $-153.0M | $37.7M | ||
| Q1 24 | $4.0M | $29.2M |
| Q4 25 | — | 51.2% | ||
| Q3 25 | — | 52.2% | ||
| Q2 25 | — | 51.5% | ||
| Q1 25 | — | 52.0% | ||
| Q4 24 | — | 50.8% | ||
| Q3 24 | — | 51.2% | ||
| Q2 24 | — | 51.0% | ||
| Q1 24 | — | 51.0% |
| Q4 25 | 9.9% | 8.1% | ||
| Q3 25 | 13.8% | 8.4% | ||
| Q2 25 | 12.8% | 8.4% | ||
| Q1 25 | 7.0% | 7.9% | ||
| Q4 24 | 7.8% | 10.7% | ||
| Q3 24 | 6.6% | 8.8% | ||
| Q2 24 | -31.3% | 7.6% | ||
| Q1 24 | 3.2% | 6.6% |
| Q4 25 | 6.8% | 4.8% | ||
| Q3 25 | 14.5% | 5.3% | ||
| Q2 25 | 8.4% | 4.9% | ||
| Q1 25 | 4.5% | 4.4% | ||
| Q4 24 | 6.1% | 6.5% | ||
| Q3 24 | 3.8% | 5.1% | ||
| Q2 24 | -30.3% | 4.0% | ||
| Q1 24 | 0.8% | 3.2% |
| Q4 25 | $0.40 | $0.45 | ||
| Q3 25 | $0.84 | $0.49 | ||
| Q2 25 | $0.46 | $0.44 | ||
| Q1 25 | $0.24 | $0.38 | ||
| Q4 24 | $0.37 | $0.58 | ||
| Q3 24 | $0.23 | $0.45 | ||
| Q2 24 | $-1.84 | $0.36 | ||
| Q1 24 | $0.05 | $0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $157.2M |
| Total DebtLower is stronger | $570.5M | $842.5M |
| Stockholders' EquityBook value | $865.9M | $823.6M |
| Total Assets | $2.2B | $2.9B |
| Debt / EquityLower = less leverage | 0.66× | 1.02× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $157.2M | ||
| Q3 25 | $340.1M | $149.2M | ||
| Q2 25 | $224.7M | $112.8M | ||
| Q1 25 | $99.0M | $92.2M | ||
| Q4 24 | $229.9M | $105.5M | ||
| Q3 24 | $103.8M | $108.0M | ||
| Q2 24 | $19.4M | $97.4M | ||
| Q1 24 | $8.0M | $97.2M |
| Q4 25 | $570.5M | $842.5M | ||
| Q3 25 | $577.2M | $862.0M | ||
| Q2 25 | $583.9M | $882.4M | ||
| Q1 25 | $590.5M | $902.8M | ||
| Q4 24 | $597.1M | $938.1M | ||
| Q3 24 | — | $978.3M | ||
| Q2 24 | — | $978.9M | ||
| Q1 24 | — | $978.4M |
| Q4 25 | $865.9M | $823.6M | ||
| Q3 25 | $890.7M | $794.2M | ||
| Q2 25 | $833.8M | $762.9M | ||
| Q1 25 | $789.2M | $699.8M | ||
| Q4 24 | $764.9M | $656.5M | ||
| Q3 24 | $732.5M | $628.5M | ||
| Q2 24 | $706.5M | $577.7M | ||
| Q1 24 | $856.2M | $550.9M |
| Q4 25 | $2.2B | $2.9B | ||
| Q3 25 | $2.2B | $2.9B | ||
| Q2 25 | $2.1B | $2.7B | ||
| Q1 25 | $2.0B | $2.7B | ||
| Q4 24 | $2.2B | $2.7B | ||
| Q3 24 | $2.1B | $2.8B | ||
| Q2 24 | $2.0B | $2.7B | ||
| Q1 24 | $2.2B | $2.7B |
| Q4 25 | 0.66× | 1.02× | ||
| Q3 25 | 0.65× | 1.09× | ||
| Q2 25 | 0.70× | 1.16× | ||
| Q1 25 | 0.75× | 1.29× | ||
| Q4 24 | 0.78× | 1.43× | ||
| Q3 24 | — | 1.56× | ||
| Q2 24 | — | 1.69× | ||
| Q1 24 | — | 1.78× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $93.2M |
| Free Cash FlowOCF − Capex | — | $57.5M |
| FCF MarginFCF / Revenue | — | 6.1% |
| Capex IntensityCapex / Revenue | — | 3.8% |
| Cash ConversionOCF / Net Profit | 3.39× | 2.05× |
| TTM Free Cash FlowTrailing 4 quarters | — | $216.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $93.2M | ||
| Q3 25 | $137.3M | $120.9M | ||
| Q2 25 | $137.2M | $69.4M | ||
| Q1 25 | $-117.5M | $51.1M | ||
| Q4 24 | $133.0M | $33.5M | ||
| Q3 24 | $91.8M | $110.7M | ||
| Q2 24 | $107.0M | $47.9M | ||
| Q1 24 | $-125.2M | $36.9M |
| Q4 25 | — | $57.5M | ||
| Q3 25 | — | $78.0M | ||
| Q2 25 | — | $49.1M | ||
| Q1 25 | — | $32.2M | ||
| Q4 24 | — | $13.4M | ||
| Q3 24 | — | $73.3M | ||
| Q2 24 | — | $28.7M | ||
| Q1 24 | — | $22.8M |
| Q4 25 | — | 6.1% | ||
| Q3 25 | — | 8.2% | ||
| Q2 25 | — | 5.3% | ||
| Q1 25 | — | 3.6% | ||
| Q4 24 | — | 1.4% | ||
| Q3 24 | — | 7.8% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 2.5% |
| Q4 25 | — | 3.8% | ||
| Q3 25 | — | 4.5% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 2.1% | ||
| Q3 24 | — | 4.0% | ||
| Q2 24 | — | 2.0% | ||
| Q1 24 | — | 1.6% |
| Q4 25 | 3.39× | 2.05× | ||
| Q3 25 | 1.91× | 2.42× | ||
| Q2 25 | 3.49× | 1.52× | ||
| Q1 25 | -5.66× | 1.30× | ||
| Q4 24 | 4.36× | 0.55× | ||
| Q3 24 | 4.72× | 2.30× | ||
| Q2 24 | — | 1.27× | ||
| Q1 24 | -31.03× | 1.26× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
SBH
| Sally Beauty Supply | $531.6M | 56% |
| Beauty Systems Group | $411.6M | 44% |
